Cencora Gross Profit 2010-2023 | COR
Cencora annual/quarterly gross profit history and growth rate from 2010 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Cencora gross profit for the quarter ending December 31, 2023 was $2.469B, a 15.05% increase year-over-year.
- Cencora gross profit for the twelve months ending December 31, 2023 was $9.282B, a 10.74% increase year-over-year.
- Cencora annual gross profit for 2023 was $8.959B, a 7.99% increase from 2022.
- Cencora annual gross profit for 2022 was $8.296B, a 19.49% increase from 2021.
- Cencora annual gross profit for 2021 was $6.943B, a 33.73% increase from 2020.
| Cencora Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $8,959 |
| 2022 | $8,296 |
| 2021 | $6,943 |
| 2020 | $5,192 |
| 2019 | $5,138 |
| 2018 | $4,612 |
| 2017 | $4,546 |
| 2016 | $4,273 |
| 2015 | $3,529 |
| 2014 | $2,982 |
| 2013 | $2,508 |
| 2012 | $2,635 |
| 2011 | $2,459 |
| 2010 | $2,325 |
| 2009 | $2,100 |
| Cencora Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2023-12-31 | $2,469 |
| 2023-09-30 | $2,253 |
| 2023-06-30 | $2,265 |
| 2023-03-31 | $2,295 |
| 2022-12-31 | $2,146 |
| 2022-09-30 | $1,986 |
| 2022-06-30 | $2,015 |
| 2022-03-31 | $2,235 |
| 2021-12-31 | $2,060 |
| 2021-09-30 | $2,069 |
| 2021-06-30 | $1,888 |
| 2021-03-31 | $1,533 |
| 2020-12-31 | $1,452 |
| 2020-09-30 | $1,347 |
| 2020-06-30 | $1,226 |
| 2020-03-31 | $1,388 |
| 2019-12-31 | $1,231 |
| 2019-09-30 | $1,185 |
| 2019-06-30 | $1,231 |
| 2019-03-31 | $1,425 |
| 2018-12-31 | $1,298 |
| 2018-09-30 | $1,033 |
| 2018-06-30 | $1,211 |
| 2018-03-31 | $1,256 |
| 2017-12-31 | $1,113 |
| 2017-09-30 | $1,172 |
| 2017-06-30 | $1,080 |
| 2017-03-31 | $1,256 |
| 2016-12-31 | $1,038 |
| 2016-09-30 | $1,125 |
| 2016-06-30 | $1,108 |
| 2016-03-31 | $1,075 |
| 2015-12-31 | $965 |
| 2015-09-30 | $974 |
| 2015-06-30 | $891 |
| 2015-03-31 | $912 |
| 2014-12-31 | $752 |
| 2014-09-30 | $873 |
| 2014-06-30 | $692 |
| 2014-03-31 | $730 |
| 2013-12-31 | $688 |
| 2013-09-30 | $568 |
| 2013-06-30 | $562 |
| 2013-03-31 | $717 |
| 2012-12-31 | $661 |
| 2012-09-30 | $703 |
| 2012-06-30 | $668 |
| 2012-03-31 | $680 |
| 2011-12-31 | $584 |
| 2011-09-30 | $538 |
| 2011-06-30 | $654 |
| 2011-03-31 | $687 |
| 2010-12-31 | $580 |
| 2010-09-30 | $561 |
| 2010-06-30 | $588 |
| 2010-03-31 | $612 |
| 2009-12-31 | $563 |
| 2009-09-30 | $539 |
| 2009-06-30 | $519 |
| 2009-03-31 | $552 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $47.415B | $262.173B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $123.860B | 15.54 |
| ICON (ICLR) | Ireland | $25.281B | 24.93 |
| DiDi Global (DIDIY) | China | $23.464B | 0.00 |
| Avantor (AVTR) | United States | $17.398B | 23.97 |
| CochLear (CHEOY) | $13.726B | 0.00 | |
| Viatris (VTRS) | United States | $13.628B | 3.89 |
| Revvity (RVTY) | United States | $12.785B | 22.26 |
| Medpace Holdings (MEDP) | United States | $12.615B | 41.50 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.511B | 0.00 |
| Charles River Laboratories (CRL) | United States | $12.369B | 22.55 |
| Natera (NTRA) | United States | $10.994B | 0.00 |
| Solventum (SOLV) | United States | $10.955B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.853B | 51.20 |
| Bausch + Lomb (BLCO) | Canada | $5.218B | 20.07 |
| Organon (OGN) | United States | $4.734B | 4.58 |
| Doximity (DOCS) | United States | $4.585B | 34.14 |
| PACS (PACS) | United States | $3.659B | 0.00 |
| Sotera Health (SHC) | United States | $3.221B | 15.81 |
| Surgery Partners (SGRY) | United States | $3.213B | 29.86 |
| Progyny (PGNY) | United States | $3.114B | 52.26 |
| Life Times (LTH) | United States | $2.882B | 31.85 |
| GoodRx Holdings (GDRX) | United States | $2.753B | 139.40 |
| Premier (PINC) | United States | $2.520B | 9.22 |
| Teladoc Health (TDOC) | United States | $2.326B | 0.00 |
| Agilon Health (AGL) | United States | $2.195B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.166B | 7.01 |
| BrightSpring Health Services (BTSG) | United States | $1.832B | 0.00 |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| Establishment Labs Holdings (ESTA) | $1.364B | 0.00 | |
| NovoCure (NVCR) | Jersey | $1.297B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.979B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.790B | 8.17 |
| Embecta (EMBC) | United States | $0.626B | 4.14 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| Enhabit (EHAB) | United States | $0.515B | 46.68 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.511B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.506B | 0.00 |
| LifeMD (LFMD) | United States | $0.440B | 0.00 |
| CareDx (CDNA) | United States | $0.426B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.419B | 0.00 |
| Beauty Health (SKIN) | United States | $0.397B | 0.00 |
| DocGo (DCGO) | United States | $0.365B | 58.33 |
| MultiPlan (MPLN) | United States | $0.361B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.323B | 0.00 |
| ModivCare (MODV) | United States | $0.320B | 4.24 |
| GeneDx Holdings (WGS) | United States | $0.313B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.285B | 0.00 |
| Sharecare (SHCR) | United States | $0.262B | 0.00 |
| Biodesix (BDSX) | United States | $0.124B | 0.00 |
| So-Young (SY) | China | $0.123B | 41.33 |
| Oncology Institute (TOI) | United States | $0.088B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.031B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.027B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.009B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |